Home
Reels
Gruplar
Sayfalar
Daha fazla gör
Gruplar Sayfalar Events Blogs Offers Jobs Courses Movies Merits
Giriş yapın Başvur
Theme Switcher
Night Mode
Sponsorluk
Blinatumomab (BLINCYTO) Prescribing Information | Hong Kong Dengyue Medicine
BLINCYTO® is the world’s first approved BiTE® immuno-oncology therapy, targeting the CD19 surface antigen on B cells. BiTE® molecules help the immune system detect and target malignant cells by bringing T cells—a type of white blood cell capable of killing cells recognized as threats—into contact with cancer cells. By positioning T cells near cancer cells, they can...
0 Yorumlar ·0 hisse senetleri ·102 Views ·0 önizleme
Please log in to like, share and comment!
Sponsorluk
Upgrade to Pro
Choose the Plan That's Right for You
Upgrade
Sponsorluk
Sponsorluk